GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas. (Q47676925)

4 February 2018

title

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas. (English)

1 reference

4 February 2018

1 reference

3

Mari Mino-Kenudson

1 reference

4 February 2018

author name string

Lauren L Ritterhouse

1

1 reference

4 February 2018

Marina Vivero

2

1 reference

4 February 2018

Lynette M Sholl

4

1 reference

4 February 2018

A John Iafrate

5

1 reference

4 February 2018

Valentina Nardi

6

1 reference

4 February 2018

Fei Dong

7

1 reference

4 February 2018

publication date

4 August 2017

1 reference

4 February 2018

published in

Modern Pathology

1 reference

4 February 2018

volume

30

1 reference

4 February 2018

page(s)

1720-1727

1 reference

4 February 2018

issue

12

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2017.88

exact match

0 references

cites work

Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

A combination of molecular markers and clinical features improve the classification of pancreatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Two G protein oncogenes in human endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Novel molecular insights from routine genotyping of colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Thyroid transcription factor 1 in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

CD74-NRG1 fusions in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Institutional implementation of clinical tumor profiling on an unselected cancer population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Anchored multiplex PCR for targeted next-generation sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Fast and accurate short read alignment with Burrows-Wheeler transform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

Clinicopathological features of lung adenocarcinoma with KRAS mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.88

7 January 2021

Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28776576

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/MODPATHOL.2017.88

1 reference

4 February 2018

PubMed ID

28776576

1 reference

4 February 2018